Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
Clinical trial NCT01666314 · COMPLETED
Trial details
- NCT number
- NCT01666314
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-20
- Primary completion
- 2013-09-12
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.